Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Data for Fig 1. by Rachael M. Giersch (22331947)

Subjects:

Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report by Nashimoto S. (17866511)

“…In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”

Decreased CD151 expression promoted coronary blood flow and mature angiogenesis. by Luying Jiang (11484407)

Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial by ALINE TABORDA FLESCH (12724983)

Ranked OD net percent decrease. by Jimy Pinto (4376539)

Yearly crude rates for alcohol-induced deaths among males by state in 2019, 2021, and 2024. by Tony Wong (779773)

Subjects:

Observed marriage survival functions in Niger and India, latest data. by Mengjia Liang (11614154)

CD4+CD8+ double positive T cells significantly increase at day 30 following IR. by Jordan A. Gunning (18143970)

Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfar... by Simon de Lusignan (2416)

Subjects:

Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. by Simon de Lusignan (2416)

Subjects:

Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison. by Simon de Lusignan (2416)

Subjects:

Crude incidence rates of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. by Simon de Lusignan (2416)

Subjects:

Unadjusted cumulative incidence of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. by Simon de Lusignan (2416)

Subjects:

Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke. by Simon de Lusignan (2416)

Subjects:

Change in use of Warfarin and DOACs over time, financial incentives to encourage increased detection in the management of AF introduced in 2014. by Simon de Lusignan (2416)

Subjects:

The impact of bacteriocin PCM7−4 on the formation of <i>L. monocytogenes</i> biofilms was observed using SEM. by Haotian Ma (11100492)